MERRELL DOW FRANCE has a total of 20 patent applications. Its first patent ever was published in 1976. It filed its patents most often in Ireland, United States and Australia. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are CORPORATION BAYER, SUZHOU PHARMAVAN CANCER RES CENTER CO LTD and LEPORI FARMA SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Ireland | 13 | |
#2 | United States | 3 | |
#3 | Australia | 2 | |
#4 | Philippines | 2 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Medical preparations | |
#5 | Peptides | |
#6 | Sugars | |
#7 | Organic chemistry methods | |
#8 | Special acyclic compounds | |
#9 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Jung Michel | 4 |
#2 | Bey Philippe | 4 |
#3 | Gerhart Fritz E | 1 |
#4 | Seiler Nikolaus J | 1 |
#5 | Metcalf Brian Walter | 1 |
#6 | Gittos Maurice Ward | 1 |
Publication | Filing date | Title |
---|---|---|
US4866206A | 2-Halomethyl derivatives of 2-amino acids | |
US4560795A | α-Halomethyl derivatives of α-amino acids | |
IE54350B1 | Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment | |
IE822935L | Pseudotropyl halogenobenzoates for migraine | |
IE821943L | Decarboxylase-inhibiting fluorinated alkane diamine derivatives | |
IE821944L | Fluorinated diamino-heptene and -heptyne derivatives | |
IE821942L | Fluorinated diaminoalkene derivatives | |
IE54258B1 | Treatment of migraine with tropyl benzoate derivatives | |
US4743691A | 2-halomethyl derivatives of 2-amino acids | |
IE861660L | Allyl derivatives |